English | Spanish
ecancer
Supporting oncology professionals through education
Login Register

The content on this site is intended for healthcare professionals only

  • Home
  • News
  • Journal
  • Video
  • elearning
  • Events
  • Conferences
  • About us
Breast Prostate & urology Lung & pleura Colorectal & gastro Melanoma & skin Head & neck Ovary & gynaecology Bone Brain & nervous system Haematology oncology Hepatobiliary pancreatic Paediatric Neuroendocrine Sarcomas

News

  • Latest news
  • Sign up for news alerts
  • Submit your news

Explore

  • Bone
  • Brain & nervous system
  • Breast
  • Colorectal & gastro
  • Haematology oncology
  • Head & neck
  • Hepatobiliary pancreatic
  • Lung & pleura
  • Melanoma & skin
  • Neuroendocrine
  • Ovary & gynaecology
  • Paediatric
  • Prostate & urology
  • Sarcomas

Journal information

  • Journal home
  • Charges
  • Editorial board
  • Founding editors
  • Editor-in-chief
  • Contact us

Author information

  • Submit article
  • Author guidelines
  • Editorial policies
  • Copyright information
  • Why publish with us

Reviewer information

  • Reviewer guidelines

Memberships

Open Access Scholarly Publishers Association Crossref Healthcare Information For All Commitee On Publication Ethics

Videos

  • Recent videos
  • Sign up

Explore

  • Bone
  • Brain & nervous system
  • Breast
  • Colorectal & gastro
  • Haematology oncology
  • Head & neck
  • Hepatobiliary pancreatic
  • Lung & pleura
  • Melanoma & skin
  • Neuroendocrine
  • Ovary & gynaecology
  • Paediatric
  • Prostate & urology
  • Sarcomas

Conferences

  • Latest conferences
  • Sign up for latest coverage
  • Submit your event

About ecancer

  • About ecancer
  • Our founders
  • Funding statement
  • Contact us
  • Home
  • News
  • Journal
  • Video
  • elearning
  • Events
  • Conferences
  • About us
Breast Prostate & urology Lung & pleura Colorectal & gastro Melanoma & skin Head & neck Ovary & gynaecology
+ -
Bone Brain & nervous system Haematology oncology Hepatobiliary pancreatic Paediatric Neuroendocrine Sarcomas

ecancer and the City Cancer Challenge have formed an educational collaboration. Learners who are part of the City Cancer Challenge's project can access additional education provided by them.

Please login or register. Then you can use this button to confirm you are part of this project.
Register for free Already have an account? Login
Videos [3422]
News [7838]
Articles [63]
Editorials [9]
Conferences [211]
elearning [49]
Researchers identify biomarkers in blood to predict liver cancer
Researchers identify biomarkers in blood to predict liver cancer
Targeting BET and OXPHOS causes synthetic lethality in liver cancer
Targeting BET and OXPHOS causes synthetic lethality in liver cancer
Centre initiates groundbreaking clinical trial with oncolytic virus for non-small cell lung cancer
Centre initiates groundbreaking clinical trial with oncolytic virus for non-small cell lung cancer
Shaping the future of neuroendocrine tumour management
Shaping the future of neuroendocrine tumour management
Hospital first-in-paediatrics to use technology that lights up lung cancer during surgery
Hospital first-in-paediatrics to use technology that lights up lung cancer during surgery
Researchers find difference in pancreatic cancer cells, offering new hope for immunotherapy effectiveness
Researchers find difference in pancreatic cancer cells, offering new hope for immunotherapy effectiveness
Kaposi sarcoma discovery could facilitate drug development
Kaposi sarcoma discovery could facilitate drug development
UK’s NICE recommends continued access to tisagenlecleucel for children and young adults with ALL
UK’s NICE recommends continued access to tisagenlecleucel for children and young adults with ALL
Positive CHMP opinion establishes amivantamab as a new treatment option in the first-line treatment of EGFR exon 20 insertion-mutated NSCLC
Positive CHMP opinion establishes amivantamab as a new treatment option in the first-line treatment of EGFR exon...
FDA approves tisotumab vedotin-tftv for recurrent or metastatic cervical cancer
FDA approves tisotumab vedotin-tftv for recurrent or metastatic cervical cancer
<1...6667686970...784>

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation

  • Contact
  • Projects
  • Cookie Policy
  • Terms of Use
  • Desktop Site
  • Privacy Policy
© 2025 ecancer, all rights reserved
UK registered charity number: 1176307
Back to Top